Sai Life Sciences to hire 700+ as Indian CRDMO sector surges
News

Sai Life Sciences to hire 700+ as Indian CRDMO sector surges

One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree

  • By IPP Bureau | February 24, 2026
Sai Life Sciences has announced plans to recruit over 700 scientific, technical, and management professionals in 2026–27 to meet growing global demand for end-to-end drug discovery, development, and manufacturing services.
 
The hiring spree will cover roles across medicinal chemistry, biology, DMPK, process and analytical development, formulation, process engineering, technology transfer, quality, peptides, business development, program management, and manufacturing.
 
A key focus will be attracting top-tier scientists from India and abroad, reflecting the rising complexity of projects being entrusted to Sai Life Sciences and the growing expectations for Indian CRDMOs from global innovator companies.
 
“We are at an inflection point for the Indian CRDMO industry. Global supply-chain rebalancing, the need for resilient development and manufacturing partners, and the rising sophistication of outsourced science are converging in India’s favour. 
 
"Demand for high-quality, integrated partners is already visible, and this expansion is about preparing ourselves to serve that demand at scale — with the right infrastructure, strong digital and quality systems, and deep scientific capability,” said Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences.
 
He added, “For scientists, this is a genuinely exciting moment. They have the opportunity to work on globally relevant, high-impact programs while being based in India. We believe this phase of growth creates a compelling opportunity for Indian scientists anywhere in the world to consider building the next chapter of their careers here—without compromising on scientific rigor, exposure, or the quality of work.”
 
The new hires will bolster operations in areas such as complex small-molecule synthesis, high-throughput experimentation, data-enabled drug discovery, and late-stage CMC and commercial manufacturing scale-up.
 
Sai Life Sciences is also launching a global alumni engagement platform and expanding learning, leadership development, and internal mobility programs to support long-term career growth.

Upcoming E-conference

Other Related stories

Startup

Digitization